DiscoverDigital Pathology Podcast154: AI in Pathology: Advances in Prostate, Bladder & Endocrine Cancer
154: AI in Pathology: Advances in Prostate, Bladder & Endocrine Cancer

154: AI in Pathology: Advances in Prostate, Bladder & Endocrine Cancer

Update: 2025-08-19
Share

Description

Send us a text

If our visual scoring is still based on gut feeling, how do we scale precision?
In this week’s DigiPath Digest, I explored four new AI-focused papers that could reshape how we diagnose prostate, bladder, gastroesophageal, and endocrine cancers.

From automated IHC scoring to predicting urethral recurrence post-cystectomy, these studies highlight the growing valueβ€”and responsibilityβ€”of integrating AI into our pathology workflows.

And yes, I also reveal where to get my histology-inspired earrings πŸ˜‰

Episode Highlights

[06:00 ] Muse Vet Platform launch + STP talk
[11:00 ] Tools I use: Perplexity, RAG, ChatGPT, and AI citation traps
[14:00 ] AI’s promiseβ€”and its pitfalls

Paper 1: IHC Scoring in GEC (Caputo et al.)

Manual PD-L1 and HER2 scoring is subjective. This study shows AI can standardize and improve accuracy using digital tools for GEC.

[20:00 ] AI reduces visual bias
[23:00 ] Potential to replace expensive assays

Paper 2: ASAP in Prostate Biopsies

Page Prostate AI matched final diagnoses 85% of the timeβ€”more than human reviewers.

[24:00 ] ASAP = gray zone diagnosis
[27:00 ] AI matched final calls more often than humans

Paper 3: Recurrence Prediction Post-Cystectomy

Chinese study developed a recurrence model using ML on clinical data. AUC: 0.86 (train), 0.77 (test).

[30:00 ] Risk factors: CIS, bladder neck involvement
[32:00 ] SHAP explained model insights

Paper 4: Reticulin Framework in Endocrine Pathology

Reticulin stains are cheap but powerful. This paper calls for AI to take notice.

[36:00 ] Reticulin separates benign from malignant
[40:00 ] Let’s train AI on these patterns

πŸ“š Resource from this Episode

  • Caputo et al., Pathology Research & Practice
  • Page Prostate study on ASAP
  • ML model predicting urethral recurrence
  • Reticulin stains in endocrine tumor grading

AI is already enhancing diagnostic precisionβ€”we just need to guide its use responsibly. From special stains to advanced models, this episode covers where we're headed next.

Support the show

Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!

CommentsΒ 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

154: AI in Pathology: Advances in Prostate, Bladder & Endocrine Cancer

154: AI in Pathology: Advances in Prostate, Bladder & Endocrine Cancer

Aleksandra Zuraw, DVM, PhD